Abstract: An optical cup which mixes multiple channels of light to form a blended output, the device having discreet zones or channels including a plurality of reflective cavities each having a remote light converting appliance covering a cluster of LEDs providing a channel of light which is reflected upward. The predetermined blends of luminescence materials provide a predetermined range of illumination wavelengths in the output. The remote light converting appliances may be provided as frustoconical elements within frustoconical reflective cavities with a void between the light converting appliances and the associated LEDs.

Abstract: A compound according to Formula Ia: wherein L1, G, and R1 are as described herein. The present invention relates to novel compounds according to Formula I that antagonize GPR84, a G-protein-coupled receptor that is involved in inflammatory conditions, and methods for the production of these novel compounds, pharmaceutical compositions comprising these compounds, and methods for the prevention and/or treatment of inflammatory conditions (for example inflammatory bowel diseases (IBD), rheumatoid arthritis, vasculitis, lung diseases (e.g. chronic obstructive pulmonary disease (COPD) and lung interstitial diseases (e.g. idiopathic pulmonary fibrosis (IPF))), neuroinflammatory conditions, infectious diseases, autoimmune diseases, endocrine and/or metabolic diseases, and/or diseases involving impairment of immune cell functions by administering a compound of the invention.

Abstract: An aqueous composition comprising basic aluminium chloride salt of formula Al2OH4.4Cl1.6 to AI2OH4.9CI1.1, calcium chloride at a molar level of 0.020 or greater relative to the aluminium present, and glycine at a molar level of 0.050 or greater relative to the aluminium present, characterised in that the molar ratio of aluminium to the sum of the molar amounts of the calcium chloride and glycine is from 3.9:1 to 6.1:1 and in that the molar ratio of glycine to Al is greater than 1.7:10 and the molar ratio of Ca to Al is less than 0.35:10 or the molar ratio of Ca to Al is greater than 0.35:10 and the molar ratio of glycine to Al is less than 1.7:10.

Abstract: Disclosed herein is a genetically modified plant of genus humulus not requiring flowering for producing lupulin glands comprising secondary compounds. Provided herein is a new plant of genus humulus having lupulin glands on non-flowering parts of the plant, such as leaves. The disclosed plants have a high mass % of secondary compounds and a high degree of lupulin glands coverage on the surface of the plant. Also disclosed herein are methods of producing secondary compounds from a plant of genus humulus without flowering the plant of genus humulus. For example, the disclosed methods provide for inducing lupulin glands development on a plant of genus humulus without flowering the plant of genus humulus.

Abstract: Lens device that includes converging lens having light output surface being spaced apart along lens axis from light input surface. Converging lens has total internal reflection side surface being spaced apart around lens axis and having frusto-conical shape extending between light input and output surfaces of the converging lens. Portion of light input surface of converging lens includes light input cavity being bounded by perimeter and having central axis and being generally shaped as portion of spheroid. Light input cavity has plurality of grooves each respectively following spline along light input surface that intersects with central axis of light input cavity and with respective point on perimeter, wherein each of respective points are mutually spaced apart around perimeter of light input cavity. Lighting system including lens device.

Abstract: A compound according to Formula Ia: wherein L1, G, and R1 are as described herein. The present invention relates to novel compounds according to Formula I that antagonize GPR84, a G-protein-coupled receptor that is involved in inflammatory conditions, and methods for the production of these novel compounds, pharmaceutical compositions comprising these compounds, and methods for the prevention and/or treatment of inflammatory conditions (for example inflammatory bowel diseases (IBD), rheumatoid arthritis, vasculitis, lung diseases (e.g. chronic obstructive pulmonary disease (COPD) and lung interstitial diseases (e.g. idiopathic pulmonary fibrosis (IPF))), neuroinflammatory conditions, infectious diseases, autoimmune diseases, endocrine and/or metabolic diseases, and/or diseases involving impairment of immune cell functions by administering a compound of the invention.

Abstract: Lighting system including mounting body, lever-locking bracket, and lighting module. Mounting body has first end spaced apart along longitudinal axis from second end. Lever-locking bracket includes bracket body and lever actuator. Lever-locking bracket is pivotally connected with first end of mounting body by flange retained in alignment with aperture of mounting body communicating with cavity inside mounting body. Lighting module has semiconductor light-emitting device in housing, and has mounting arm pivotally connected with lever-locking bracket by first pivot joint for rotation of lighting module to plurality of primary positions around first pivot axis. Flange of the lever-locking bracket forms part of second pivot joint for rotation of lighting module to plurality of secondary positions around second pivot axis.

Abstract: A compound according to Formula Ia: wherein Cy, L1, G, and R1 are as described herein. The present invention relates to novel compounds according to Formula I that antagonize GPR84, a G-protein-coupled receptor that is involved in inflammatory conditions, and methods for the production of these novel compounds, pharmaceutical compositions comprising these compounds, and methods for the prevention and/or treatment of inflammatory conditions (for example inflammatory bowel diseases (IBD), rheumatoid arthritis, vasculitis), lung diseases (e.g. chronic obstructive pulmonary disease (COPD) and lung interstitial diseases (e.g. idiopathic pulmonary fibrosis (IPF))), neuroinflammatory conditions, infectious diseases, autoimmune diseases, endocrine and/or metabolic diseases, and/or diseases involving impairment of immune cell functions by administering a compound of the invention.

Abstract: Lighting system including mounting body, lever-locking bracket, and lighting module. Mounting body has first end spaced apart along longitudinal axis from second end. Lever-locking bracket includes bracket body and lever actuator. Lever-locking bracket is pivotally connected with first end of mounting body by flange retained in alignment with aperture of mounting body communicating with cavity inside mounting body. Lighting module has semiconductor light-emitting device in housing, and has mounting arm pivotally connected with lever-locking bracket by first pivot joint for rotation of lighting module to plurality of primary positions around first pivot axis. Flange of the lever-locking bracket forms part of second pivot joint for rotation of lighting module to plurality of secondary positions around second pivot axis.

Abstract: An optical cup which mixes multiple channels of light to form a blended output, the device having discreet zones or channels including a plurality of reflective cavities each having a remote phosphor light converting appliance covering a cluster of LEDs providing a channel of light which is reflected upward. The predetermined blends of phosphors provide a predetermined range of illumination wavelengths in the output.

Abstract: An optical cup which mixes multiple channels of light to form a blended output, the device having discreet zones or channels including a plurality of reflective cavities each having a remote light converting appliance covering a cluster of LEDs providing a channel of light which is reflected upward. The predetermined blends of luminescence materials provide a predetermined range of illumination wavelengths in the output. The remote light converting appliances may be provided as frustoconical elements within frustoconical reflective cavities with a void between the light converting appliances and the associated LEDs.

Abstract: An optical cup which mixes multiple channels of light to form a blended output, the device having discreet zones or channels including a plurality of reflective cavities each having a remote phosphor light converting appliance covering a cluster of LEDs providing a channel of light which is reflected upward. The predetermined blends of phosphors provide a predetermined range of illumination wavelengths in the output.

Abstract: Lighting system including housing having base plate, and housing wall projecting in upward direction. Container with LED in housing having visible light-transmissive top plate and container wall projecting in downward direction. Gasket is configured for forming seal between container wall and base plate to form sealed container. Rail interposed between interior side of housing wall and exterior side of container wall. Rail has first side facing towards interior side of housing wall and second side facing toward exterior side of container wall. First raised region forms part of interior side of housing wall or part of first side of rail. Second raised region forms part of exterior side of container wall or part of second side of rail. First raised region is configured for limiting movement of rail away from base plate along upward direction, and second raised region is configured for limiting such movement of container wall.

Abstract: An optical cup which mixes multiple channels of light to form a blended output, the device having discreet zones or channels including a plurality of reflective cavities each having a remote phosphor light converting appliance covering a cluster of LEDs providing a channel of light which is reflected upward. The predetermined blends of phosphors provide a predetermined range of illumination wavelengths in the output.